Skip to content

Capital raising and
ASX dual listing

  • Cameron Partners advised Pacific Edge in relation to its NZ$104m capital raising and ASX dual listing

  • The placement was heavily subscribed with New Zealand, Australian, and global institutional investors participating in the transaction

  • Pacific Edge develops pioneering cancer diagnostics tools and is commercialising its Cxbladder diagnostics product suite in New Zealand, the US, and globally